Eugene Daphnis

Eugene Daphnis

Auto-generated profile, based on publicly available information

Eugene Daphnis

Nephrology, University Hospital of Heraklion, 71110 Crete, Greece

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2012 in Lupus
Verified
Journal Article
Closed access
DMDk Moysiadis
Dk Moysiadis
GPGs Perysinaki
Gs Perysinaki
GBG Bertsias
G Bertsias
SSS Stratakis
S Stratakis
KKK Kyriacou
K Kyriacou
EDE Daphnis
E Daphnis
Renal podocytes and their slit diaphragms ensure the integrity of renal basement membrane and prevent urinary protein loss. We have previously reported that decreases of the podocyte slit diaphragm proteins nephrin and podocin represent early events in the podocytopathy of lupus nephritis (LN). We asked whether immunosuppressive agents such as glucocorticoids and cyclophosphamide may have direct effects on podocytes. We assessed in New Zealand Black/New Zealand White (NZB/W) F1 LN mice glomerular nephrin and podocin expression and localization by the use of Western blot and immunofluorescence; mRNA levels were measured by real-time polymerase chain reaction (PCR) and renal histology by light and electron microscopy. Early treatment with glucocorticoids and cyclophosphamide halted the histologic alterations associated with LN, preserving podocyte foot processes. Nephrin and podocin protein expression significantly increased in both glucocorticoid and cyclophosphamide groups as early as after three months of therapy. Real-time PCR revealed similar enhancement in nephrin and podocin mRNA levels after three to six months of treatment. This study documents that early treatment in experimental LN with glucocorticoids or cyclophosphamide preserves slit diaphragm proteins in podocytes and halts histological changes of the glomeruli, thus raising the possibility of a direct protective effect of these drugs on podocytes.

9 November 2018 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DMDiamantina Marouli
Diamantina Marouli
KSKostas Stylianou
Kostas Stylianou
EPEleftherios Papadakis
Eleftherios Papadakis
NKNikolaos Kroustalakis
Nikolaos Kroustalakis
SKStavroula Kolyvaki
Stavroula Kolyvaki
HAHelen Askitopoulou
Helen Askitopoulou
Background: Postoperative Acute Kidney Injury (AKI) is a common and serious complication associated with significant morbidity and mortality. While several pre- and intra-operative risk factors for AKI have been recognized in cardiac surgery patients, relatively few data are available regarding the incidence and risk factors for perioperative AKI in other surgical operations. The aim of the present study was to determine the risk factors for perioperative AKI in patients undergoing major abdominal surgery. Methods: This was a prospective, observational study of patients undergoing major abdominal surgery in a tertiary care center. Postoperative AKI was diagnosed according to the Acute Kidney Injury Network criteria within 48 h after surgery. Patients with chronic kidney disease stage IV or V were excluded. Logistic regression analysis was used to evaluate the association between perioperative factors and the risk of developing postoperative AKI. Results: Eleven out of 61 patients developed postoperative AKI. Four intra-operative variables were identified as predictors of AKI: intra-operative blood loss (p = 0.002), transfusion of fresh frozen plasma (p = 0.004) and red blood cells (p = 0.038), as well as high chloride load (p = 0.033, cut-off value > 500 mEq). Multivariate analysis demonstrated an independent association between AKI development and preoperative albuminuria, defined as a urinary Albumin to Creatinine ratio ≥ 30 mg·g−1 (OR = 6.88, 95% CI: 1.43–33.04, p = 0.016) as well as perioperative chloride load > 500 mEq (OR = 6.87, 95% CI: 1.46–32.4, p = 0.015). Conclusion: Preoperative albuminuria, as well as a high intraoperative chloride load, were identified as predictors of postoperative AKI in patients undergoing major abdominal surgery.

24 October 2008 in Kidney
Verified
Journal Article
Closed access
PDF file
KSKostas Stylianou
Kostas Stylianou
APAndrew Passam
Andrew Passam
APAntonios Papoutsakis
Antonios Papoutsakis
KPKostas Perakis
Kostas Perakis
NKNikolaos Kroustalakis
Nikolaos Kroustalakis
EDEugene Daphnis
Eugene Daphnis

10 September 2010 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
KSKostas Stylianou
Kostas Stylianou
SSStavros Stratakis
Stavros Stratakis
VMVasiliki Mavroeidi
Vasiliki Mavroeidi
IPIoannis Petrakis
Ioannis Petrakis
DXDIMITRIOS XYDAKIS
DIMITRIOS XYDAKIS
EDEugene Daphnis
Eugene Daphnis
The kidney is increasingly recognised as a target organ of chronic graft-versus-host disease after hematopoietic cell transplantation in the context of the development of the nephrotic syndrome. Chronic graft-versus-host disease is associated with autoimmune phenomena similar, but not identical, to those observed in various rheumatologic disorders, implicating autoimmunity as an important component of the disease.

12 May 2009 in Cases Journal
Verified
Journal Article
Open access
PDF file
KSKostas Stylianou
Kostas Stylianou
GTGeorge Tsirakis
George Tsirakis
EMElpis Mantadakis
Elpis Mantadakis
IXIrini Xylouri
Irini Xylouri
AFAndreas Foudoulakis
Andreas Foudoulakis
VGVassilis Georgoulias
Vassilis Georgoulias
Introduction: Thrombotic microangiopathies constitute a heterogeneous group of diseases characterised by microangiopathic haemolytic anaemia and thrombocytopaenia associated with platelet aggregation in the microcirculation responsible for ischaemic manifestations. Classically, thrombotic microangiopathies are described as encompassing two main syndromes: thrombotic thrombocytopaenic purpura and the haemolytic-uraemic syndrome Many cases of idiopathic thrombotic thrombocytopaenic purpura have, to date, been associated with severe ADAMTS13 metalloprotease deficiency while haemolytic uraemic syndrome usually occurs in the context of normal protease activity. Oestrogens and factor V Leiden have rarely been implicated in the pathogenesis of thrombotic microangiopathy. Case presentation: We describe the case of a 17-year-old female with refractory thrombotic thrombocytopaenic purpura. The patient was receiving a new generation of oral contraceptives for dysmenorrhoea and had factor V Leiden. After undergoing prolonged and intense plasma exchange therapy for 40 days and high dose oral corticosteroids therapy for 90 days, our patient recovered fully. Conclusion: Patients with refractory thrombotic thrombocytopaenic purpura should likely be evaluated for congenital thrombophilic disorders and for ingestion of drugs that have been associated with this rare form of thrombotic microangiopathy. Identification of these and as yet other unknown genetic and/or acquired risk factors may lead to more judicious treatment approaches.

24 April 2007
Verified
Closed access
SKSophia Koukouraki
Sophia Koukouraki
MSMaria Stathaki
Maria Stathaki
KSKostas Stylianou
Kostas Stylianou
EDEugene Daphnis
Eugene Daphnis
NKNikolaos Karkavitsas
Nikolaos Karkavitsas